NATCO Pharma Q3 Results: Profit declines 37% to Rs 132 crore
NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports.…
Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug
Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary CuraTeQ Biologics received approval from the UK‘s Medicines and Healthcare products Regulatory Agency…